Key Takeaways
- The dental practice sale process is a controlled, multi-phase sequence where valuation quality and competitive tension can be some of the main factors that determine the final outcome.
- Doctor-to-doctor sales typically suit $1–1.5 million practices with cash at close and a short 4–8 week work-back, while DSO/private-equity deals suit larger practices and usually require a minimum five-year working agreement.
- A CPA-led, diligence-grade EBITDA valuation that unpacks add-backs and normalizes owner compensation is essential to reduce the risk of re-trading during due diligence.
- Representation by a dental-specific sell-side advisor running a structured, competitive bid process among vetted buyers can produce an 85–90% transaction rate versus the industry norm of 35–40%.
- McLerran & Associates is a dental-specific sell-side advisor for the dental practice sale process because it runs both the doctor-to-doctor and DSO/private-equity paths in roughly equal measure, builds a CPA-led, diligence-grade EBITDA valuation up front, and creates a structured competitive bid process among a vetted buyer pool.
Schedule a Discovery Call with McLerran & Associates
What Are the Steps in the Dental Practice Sale Process?
The dental practice sale process can be organized into seven sequential phases, and each phase carries its own risks and decisions. Every phase has a distinct purpose, a different set of decision-makers, and specific points where deals can stall or collapse.
- Pre-sale planning: Clarifying the owner's goals, cleaning up financials, and building the runway before going to market.
- Valuation and EBITDA analysis: Establishing a defensible, diligence-grade asking price using the right method for the intended buyer type.
- Assembling the advisory team: Engaging a dental-specific sell-side advisor, a dental M&A attorney, and a CPA with dental transaction experience.
- Choosing the path and buyer type: Deciding between a doctor-to-doctor sale and a DSO/private-equity affiliation, or running both in parallel to compare outcomes.
- Marketing and confidentiality: Taking the practice to market without destabilizing staff, patients, or referral relationships.
- LOI and due diligence: Negotiating the letter of intent (LOI), defending the valuation through the buyer's quality-of-earnings review, and managing the path to a signed purchase agreement.
- Closing and post-sale transition: Executing the asset purchase agreement, assigning the lease, completing credentialing, and managing the seller's work-back obligations.
The table below shows how much timing varies by phase. Only a few phases have reliable benchmarks, while most depend on readiness, financing, and landlord cooperation rather than a fixed calendar.
| Phase | Typical Duration |
|---|---|
| Pre-sale planning / runway | Variable, advisors commonly recommend roughly 2–5 years, with some citing 12–24 months as a practical minimum and others recommending starting 5–10 years before an exit |
| Valuation and EBITDA analysis | Variable, approximately one month for a CPA-led analysis |
| Advisory team assembly | Variable, often concurrent with valuation |
| Path selection and marketing | Variable, weeks to several months depending on buyer pool and practice readiness |
| DSO/PE competitive bid process | ~45–60 days, typically generating around 10 offers |
| LOI to closing (due diligence + purchase agreement) | Variable, commonly 30–90 days, driven by diligence responsiveness, lease assignment, landlord consent, and credentialing |
| Post-sale work-back (doctor-to-doctor walk-away) | ~4–8 weeks |
| Post-sale work-back (DSO/PE affiliation) | Typically a minimum 5-year working agreement |
Phase 1: Pre-Sale Planning and the Runway
The most consequential decisions in a dental practice sale often happen long before a buyer sees the practice. Pre-sale planning covers financial cleanup, documentation readiness, lease management, and the owner's personal "why" such as retirement, staff burden, growth capital, or taking chips off the table.
Multiple transition advisors recommend beginning preparation roughly 12–24 months before a target closing date. Some advisors recommend longer runways of 2–5 years, and DSO-bound sellers often benefit from even more time. DSO deals typically require a minimum five-year working agreement, so an owner who waits until they are emotionally ready to exit may have already limited the DSO path. Private buyers evaluate three years of financials, so the financial cleanup that moves a practice's sale number usually happens in the years before listing.
Practical pre-sale tasks include reconciling tax returns with practice management software reports, removing personal expenses from the P&L, confirming the lease has sufficient remaining term and is assignable, and stabilizing the provider team. Sellers whose materials are built to buyer standards before going to market often move through diligence in weeks, while sellers reconstructing answers under deadline pressure can watch every reconstructed answer invite two new questions.
If an owner is not yet ready to sell, McLerran & Associates can complete a full valuation and update it at no charge a year later. That approach helps the owner enter the market with current, defensible numbers rather than a stale estimate.
Phase 2: Valuation and EBITDA Analysis in the Dental Practice Sale Process
Once the financials are clean and the runway is set, the next step is determining what the practice is actually worth. Valuation is where much of the financial damage in a dental practice sale can occur quietly. A back-of-the-napkin number set by the buyer, or by a firm offering a free valuation as a lead magnet, often becomes the anchor that determines what the owner walks away with. A weak valuation analysis tends to get re-traded in due diligence, while a diligence-grade valuation is built to withstand that review.
The right valuation method depends on the intended buyer type. Doctor-to-doctor deals are typically priced as a percentage of annual collections or a multiple of seller's discretionary earnings (SDE, which is net income before the owner's compensation and personal expenses). DSO and private-equity deals are priced on a multiple of adjusted EBITDA, which resets the owner's pay to a market-rate associate dentist and removes non-recurring and personal expenses. A percentage-of-collections quote and an EBITDA-multiple quote measure value differently, so they must be converted to the same terms before comparison.
Multiples are driven by fundamentals rather than a fixed table. Larger practices with multiple doctors, durable revenue, room to expand, stronger EBITDA, favorable payer mix, higher hygiene share, and certain specialties can often support higher multiples. Heavy owner-doctor dependence, where the owner produces 90% or more of revenue, can reduce a valuation by an estimated 10–20%.
Collections-based rules of thumb circulate widely as shortcuts and can provide a rough orientation. They rarely unpack add-backs, normalize owner compensation, or hold up when a buyer's quality-of-earnings team scrutinizes the numbers. McLerran & Associates has evaluated more than 10,000 practices and produces a side-by-side valuation that quantifies a practice's worth in both the private-buyer and DSO markets, so owners compare real numbers instead of guesses.
Phase 3: Assembling the Advisory Team for a Dental Practice Transition
A dental practice sale typically calls for a team of dental-specific advisors. This team commonly includes a practice valuator or broker, a dental M&A attorney, and a CPA with dental transaction experience. Each advisor plays a distinct role, and none fully replaces the others.
The sell-side advisor manages the overall process, including valuation, marketing, buyer outreach, competitive tension, LOI negotiation, and diligence management. The attorney drafts and negotiates the purchase agreement, lease assignment, non-compete, and transition agreement. The CPA handles tax structuring, purchase price allocation, and, in a DSO deal, models the after-tax proceeds across deal structures and time horizons.
McLerran & Associates is sell-side only, so its client is always the practice owner. The firm makes introductions to attorneys, lenders, and specialists who know dentistry, but it stays in its lane and does not represent the buyer. That alignment matters because some advisors in the DSO world present themselves as sell-side advisors while working for whichever party pays their fee, which can create conflicts with a seller-focused role.
Phase 4: Choosing the Path, Doctor-To-Doctor Sale or DSO/Private-Equity Affiliation
This phase is the divergence point where the owner chooses a path. The two paths differ in valuation method, deal structure, post-close obligations, and the type of buyer the owner will work with in the next chapter of their career.
Doctor-to-doctor sale is typically the right fit for premier practices in roughly the $1–1.5 million annual revenue range. The buyer is another dentist, and financing is usually SBA or conventional. The transaction is typically structured as an asset sale, and private buyers usually pay most or all of the purchase price in cash at closing. The post-sale transition is usually short. The seller typically works back approximately 4–8 weeks, introduces the buyer to patients and staff, and then exits. A partnership or vest-out structure, where the owner sells roughly 50% now to a future partner who buys the remainder over time, can fit practices large enough to support two or more doctors.
DSO/private-equity affiliation is generally on the table for practices generating $1.5 million or more in annual revenue. Owners in the $1.5–3 million middle can often go either path, and practices generating $3 million or more usually point toward the DSO/private-equity path. The deal structure is more complex and often includes cash at close, retained equity at either the joint-venture or holding-company level, and an earnout tied to post-close performance. A DSO or corporate-group acquisition typically pays only a portion of the purchase price at closing, with the remaining amount delivered through an earnout or retained equity. A minimum five-year working agreement is standard.
Owners in the $1.5–3 million revenue range can often pursue either path. They benefit from a side-by-side valuation that quantifies their worth in both markets, a capability McLerran & Associates offers because it runs both paths in roughly equal measure. Learn more about the DSO and private-equity path.
Phase 5: Marketing, Confidentiality, and Buyer Outreach
The marketing phase focuses on exposing the practice to qualified buyers while protecting confidentiality. A practice usually goes to market without a name attached, and the listing describes the area, collections, operatories, and patient count. Buyers sign a non-disclosure agreement (NDA) before they receive identifying information, which allows showings to be scheduled after business hours or on closed days without alerting staff or patients. Staff, patients, competitors, and vendors should hear about a transition only after the owner has a communication and continuity plan in place.
The quality of the buyer pool can be as important as its size. Going it alone or working with a local generalist broker often means exposure to one buyer or a small handful of DSOs, which limits competitive tension and makes it hard to know whether that buyer is a strong fit. An advisor-run process approaches vetted DSO, private-equity, and individual buyers directly under NDA to create competitive tension and negotiate structure, equity rollover, and transition terms in the seller's favor. That approach differs from a public listing that draws one inbound offer at a time.
McLerran & Associates maintains access to the largest premier private-buyer pool in the country and a pre-vetted DSO/PE buyer pool with poorly run buyers removed. That vetting matters because sellers evaluating PE-backed or DSO buyers should analyze not only price but also rollover equity, leverage, governance, clinical autonomy, and the buyer's ability to support the practice.
Phase 6: LOI, Due Diligence, and Quality-of-Earnings Defense
The letter of intent (LOI) is the document that locks in the principal deal terms before binding legal drafting begins. The LOI is mostly non-binding on price and terms but binding on exclusivity, which means the moment before signing is often the seller's point of maximum negotiating leverage because they typically stop talking to other buyers afterward.
Key LOI terms that are usually negotiable include valuation, cash at close, equity structure at the joint-venture or holding-company level, earnout terms, and the asset versus stock sale election. On earnouts, McLerran & Associates often pushes for non-punitive, pro-rata provisions so a near-miss on an EBITDA target still pays most of the earnout, and for a later start date to account for integration disruption.
Re-trading, where a buyer returns after diligence with a lower number, is one of the most common ways deals shrink after an LOI is signed. Undocumented add-backs are the most common finding in dental practice diligence by a wide margin; an add-back the seller can describe is worth nothing, while an add-back with an invoice attached is worth its face value multiplied by the valuation multiple. A buyer who discovers one item that was not as described often re-prices the credibility of every item still outstanding, which is the mechanic behind many re-trades.
McLerran & Associates' structured bid process typically runs approximately 45–60 days and generates around 10 offers. That competitive tension can be one of the most effective defenses against re-trading because a buyer who tries to reduce the price knows that other vetted bidders are still active.
Get a Diligence-Grade Valuation
Phase 7: Closing and Post-Sale Transition
The closing phase converts the LOI into a binding asset purchase agreement and finalizes the transition. The key documents include the purchase agreement, bill of sale, lease assignment, non-compete agreement, and the seller's transition or employment agreement. Insurance credentialing does not transfer with a dental practice sale and can take several months, so the buyer should begin credentialing immediately after the LOI is signed.
Most dental practice sales are structured as asset sales, where the buyer purchases equipment, patient records, and goodwill rather than the seller's legal entity. Both parties must file IRS Form 8594 reporting how the purchase price is allocated across asset classes, because the allocation affects taxes for both sides. Goodwill is typically taxed at long-term capital gains rates for the seller. Equipment may be subject to depreciation recapture at ordinary income rates. Non-compete payments are taxed as ordinary income. Sellers should consult a qualified tax advisor before finalizing any allocation.
The seller's post-close role differs sharply by path. In a doctor-to-doctor walk-away sale, the seller typically works back approximately 4–8 weeks, introduces the buyer to patients and staff, and then exits. In a DSO affiliation, a minimum five-year working agreement is now standard, during which the seller becomes an employee rather than an owner. The seller's work-back obligations, schedule, and compensation are negotiated at the LOI stage and should appear clearly in the purchase agreement.
McLerran & Associates reports a transaction rate of roughly 85–90% among its clients, compared to an industry norm closer to 35–40% and a do-it-yourself close rate as low as 15–20%. That gap reflects the difference between a controlled, advocate-driven process and an unrepresented seller negotiating alone.
How Long Does the Dental Practice Sale Process Take and How Hard Is It?
The dental practice sale process often takes longer and feels harder than most owners expect. Most dental practice sales take 6–12 months from advisor engagement to closing, and a well-run process can sometimes finish faster. The DSO competitive bid process itself usually runs approximately 45–60 days, and the doctor-to-doctor work-back after closing often runs approximately 4–8 weeks. Every other phase, including pre-sale preparation, valuation, marketing, LOI negotiation, diligence, and lease assignment, is variable and driven by financial readiness, lease term, buyer financing, landlord consent, and credentialing timelines.
Deals can be fragile and may collapse at multiple points. Common issues include a quality-of-earnings review that finds undocumented add-backs, a landlord who delays lease consent, a buyer whose financing falls short of the agreed price, or a seller who is not emotionally prepared to close. Sellers who are not emotionally prepared can subconsciously sabotage their own deals by making non-market demands close to closing. Representation by a dental-specific sell-side advisor can mitigate many of these failure points by anticipating risks, preparing documentation in advance, and maintaining competitive tension so the seller has options if a buyer tries to renegotiate.
Conclusion: Moving Through the Dental Practice Sale Process With an Advocate
The dental practice sale process is a controlled sequence in which valuation quality and competitive tension determine the outcome, which differs significantly from simply listing a practice and waiting for offers. McLerran & Associates is a dental-specific sell-side advisor for the dental practice sale process because it runs both the doctor-to-doctor and DSO/private-equity paths in roughly equal measure, builds a CPA-led, diligence-grade EBITDA valuation up front, and creates a structured competitive bid process among a vetted buyer pool.
Owners who are considering a transition, whether now or in the next several years, often benefit from acting before they feel fully ready. Clarifying goals, reviewing financials, and getting a real valuation before going to market can be some of the main factors that shape the final outcome. The runway is often the most valuable asset in the process, and once time passes it cannot be recovered.
For more on preparing your practice, see How to Prepare Your Dental Practice for Sale and The Dental Practice Sale Process: A Phase-By-Phase Guide.
Get a Confidential Read on Your Practice's Value
Frequently Asked Questions About the Dental Practice Sale Process
How Long Does It Take to Sell a Dental Practice?
Most dental practice sales take 6–12 months from advisor engagement to closing, though a well-run process can sometimes finish faster. Pre-sale preparation, including cleaning up financials, confirming lease assignability, and stabilizing the provider team, commonly begins roughly 12–24 months before a target closing date, and some advisors recommend 2–5 year runways. DSO-bound sellers often benefit from a longer runway because DSO deals typically require a minimum five-year working agreement. The phases most likely to extend the timeline include landlord consent for lease assignment, buyer financing approval, and insurance credentialing, which rarely follow a fixed calendar.
How Hard Is It to Sell a Dental Practice?
Selling a dental practice is often significantly harder than most owners anticipate. Do-it-yourself close rates can run as low as 15–20%, compared to roughly 85–90% for a well-represented seller working with a dental-specific advisor. Deals can collapse during quality-of-earnings review, at lease assignment, at financing, or when a seller is not emotionally prepared to close. The information gap between a once-in-a-lifetime seller and buyers who negotiate regularly is a core challenge, and professional representation is one of the primary ways to narrow that gap.
How Is a Dental Practice Valued When Selling?
The valuation method usually depends on the intended buyer. Doctor-to-doctor deals are typically priced as a percentage of annual collections or a multiple of seller's discretionary earnings (SDE). DSO and private-equity deals are priced on a multiple of adjusted EBITDA, which reflects the practice's operating profit after normalizing the owner's compensation to a market-rate associate dentist and removing personal and non-recurring expenses. Multiples vary based on practice size, number of doctors, revenue durability, payer mix, hygiene share, specialty, and expandability. A diligence-grade, CPA-led valuation unpacks every add-back so the number can hold up when buyers scrutinize it, while a back-of-the-napkin estimate often cannot.
Should I Sell to a Private Buyer or a DSO?
The right path depends on practice size, profitability, and the owner's personal goals. Smaller premier practices, commonly in the $1–1.5 million revenue range, often fit a doctor-to-doctor sale, which typically delivers 100% cash at close and a short work-back. Larger practices, generally $1.5 million and above, are more likely to attract DSO or private-equity interest, which can produce a higher headline valuation but involves a more complex deal structure with cash, equity, and earnout, along with a multi-year working commitment. Owners in the $1.5–3 million revenue range can often go either way and benefit from a side-by-side valuation that quantifies their worth in both markets before choosing.
Do I Have to Keep Working After I Sell?
In a DSO or private-equity affiliation, a minimum five-year working agreement is now a common post-close commitment. The seller becomes an employee rather than an owner during that period, and clinical autonomy terms vary by buyer and are negotiable at the LOI stage. In a doctor-to-doctor walk-away sale, the seller typically works back approximately 4–8 weeks to introduce the buyer to patients and staff, then exits. A partnership or vest-out structure, where the owner sells roughly 50% now with the remainder purchased over time, falls between these two options and creates a longer but defined transition period.
Why Use a Dental-Specific Sell-Side Advisor Instead of a Local Broker?
A local generalist broker who knows only a small number of buyers often provides limited market exposure, weaker valuation work, and less aggressive bidding because buyers tend to bid less aggressively on deals from advisors who transact infrequently. A dental-specific sell-side advisor runs a full competitive process among a vetted national buyer pool, produces a diligence-grade valuation that can withstand scrutiny, and maintains competitive tension through closing so the agreed value is more likely to hold. McLerran & Associates reports a transaction rate of roughly 85–90% among its clients, compared to an industry norm closer to 35–40%, and is sell-side only, so its incentives are fully aligned with the practice owner, never the buyer.
